Regulation of cytokine signaling and inflammation

被引:593
作者
Hanada, T [1 ]
Yoshimura, A [1 ]
机构
[1] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan
关键词
cytokine signaling; inflammation; interleukin;
D O I
10.1016/S1359-6101(02)00026-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inflammation progresses by the action of pro-inflammatory cytokines, including interleukin-1 (IL-1), the tumor necrosis factor (TNF), gamma-interferon (IFNgamma), IL-12, IL-18, and the granulocyte-macrophage colony-stimulating factor, and is resolved by anti-inflammatory cytokines such as IL-4, IL-10, IL-13, IFNalpha, and the transforming growth factor (TGF)beta. The intracellular signal transduction pathways of these cytokines have been studied extensively, and these pathways ultimately activate transcription factors, such as NF-kappaB, Smad, and STATs. Recently, the negative-feedback regulation of these pathways has been identified. In this review, we provide examples of the relationship between cytokine signal transduction, negative-signal regulation, and inflammatory disease models. Furthermore, we illustrate several approaches for treating inflammatory diseases by modulating extracellular and intracellular signaling pathways. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:413 / 421
页数:9
相关论文
共 88 条
  • [1] Toll-like receptors: critical proteins linking innate and acquired immunity
    Akira, S
    Takeda, K
    Kaisho, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 675 - 680
  • [2] SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine
    Alexander, WS
    Starr, R
    Fenner, JE
    Scott, GL
    Handman, E
    Sprigg, NS
    Corbin, JE
    Cornish, AL
    Darwiche, R
    Owczarek, CM
    Kay, TWH
    Nicola, NA
    Hertzog, PJ
    Metcalf, D
    Hilton, DJ
    [J]. CELL, 1999, 98 (05) : 597 - 608
  • [3] Aronica MA, 1999, J IMMUNOL, V163, P5116
  • [4] Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
    Atreya, R
    Mudter, J
    Finotto, S
    Müllberg, J
    Jostock, T
    Wirtz, S
    Schütz, M
    Bartsch, B
    Holtmann, M
    Becker, C
    Strand, D
    Czaja, J
    Schlaak, JF
    Lehr, HA
    Autschbach, F
    Schürmann, G
    Nishimoto, N
    Yoshizaki, K
    Ito, H
    Kishimoto, T
    Galle, PR
    Rose-John, S
    Neurath, MF
    [J]. NATURE MEDICINE, 2000, 6 (05) : 583 - 588
  • [5] Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease
    Babyatsky, MW
    Rossiter, G
    Podolsky, DK
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : 975 - 984
  • [6] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [7] LPS and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages
    Bode, JG
    Nimmesgern, A
    Schmitz, J
    Schaper, F
    Schmitt, M
    Frisch, W
    Hussinger, D
    Heinrich, PC
    Graeve, L
    [J]. FEBS LETTERS, 1999, 463 (03) : 365 - 370
  • [8] Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1β on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells
    Boisclair, YR
    Wang, JR
    Shi, JR
    Hurst, KR
    Ooi, GT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (06) : 3841 - 3847
  • [9] Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: Evidence for an IL-10-induced pathway that is independent of STAT protein activation
    Cassatella, MA
    Gasperini, S
    Bovolenta, C
    Calzetti, F
    Vollebregt, M
    Scapini, P
    Marchi, M
    Suzuki, R
    Suzuki, A
    Yoshimura, A
    [J]. BLOOD, 1999, 94 (08) : 2880 - 2889
  • [10] CHEN CC, 1995, J IMMUNOL, V155, P3538